r more than two decades Regeneron has discovered, developed, and commercialized medicines for the treatment of serious medical conditions right here in New York," said Empire State Development Chairman and CEO designate, Dennis Mullen. "They have invested millions into the New York economy, and employ more than 1,000, with nearly 750 jobs in Tarrytown and more than 250 in Rensselaer. Today's opening of their new headquarters means we are securing those jobs for New York State. Regeneron is an example of the type of investment which will foster sustainable growth, create jobs, revive our economy and expand opportunities for all New Yorkers."
The new facilities offer environmentally friendly design features, including a white roof to reflect heat, a high efficiency HVAC system, building layouts for laboratories and offices to maximize day lighting, a courtyard located between buildings that maximizes permeable surfaces to reduce water runoff, and extensive use of sustainable materials such as bamboo flooring and low volatility organic compounds. In addition, as part of The Landmark at Eastview campus, employees are provided complimentary shuttle service to the North White Plains and Tarrytown Metro North Stations and convenient access to other public transportation.
The Landmark at Eastview is one of the largest privately-owned, multi-tenant science parks in New York State. The campus consists of eight buildings and over 1.1 million rentable square feet of research and development facilities and high-tech office space. Construction of a third lab-ready building was initiated and completed concurrently with the core and shell construction for Regeneron's two new buildings.
About Regeneron Pharmaceuticals
Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection
Page: 1 2 3 4 5 Related biology technology :1
|SOURCE BioMed Realty Trust, Inc.; Regeneron Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey2
. Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology3
. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals4
. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes5
. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results6
. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML7
. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 20078
. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results9
. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences10
. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer11
. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences